Investor Firms Press Telix Shareholders as Lead-Plaintiff Deadline Nears

Overview

• On December 17, 2025, Faruqi & Faruqi, the Law Offices of Howard G. Smith, and Rosen Law Firm issued investor notices highlighting the lead-plaintiff deadline.
• The firms say a securities class action has been filed, and Rosen notes that no class has been certified.
• The putative class covers purchases of Telix securities from February 21, 2025 through August 28, 2025.
• The complaint alleges Telix overstated progress on prostate cancer therapeutic candidates as well as the quality of its supply chain and partners.
• Telix disclosed an SEC subpoena on July 22, 2025, followed by a more than 13% two-session ADS decline, and an FDA Complete Response Letter on August 28, 2025 citing CMC deficiencies and Form 483s, after which ADSs fell more than 21% over two sessions.